SF3A3 Peptide (AAP40684)
Product Specifications
Gene Aliases
PRP9, PRPF9, SAP61, SF3a60
Gene ID
10946
Accession Number
NP_006793
Target
This is a synthetic peptide designed for use in combination with anti-SF3A3 antibody (Catalog #: ARP40684_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Partner Proteins
SF3A1, ADAP1, CCDC85B, SF3A1, SFRS12, TCERG1, U2AF1, CCDC85B, PUF60, RAE1, SF3A1, SF3A2, SMNDC1, TCERG1
Type
Blocking Peptide
Applications
WB
Assay Protocol
Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions
Reconstitution & Storage Instructions
Western Blotting/Immunoblotting (WB/IB) Protocol
Western Blotting/Immunoblotting (WB/IB) Protocol
Immunohistochemistry (IHC) Protocol
Immunohistochemistry (IHC) Protocol
Immunocytochemistry (ICC) Protocol
Immunocytochemistry (ICC) Protocol
Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol
Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol
Blocking Peptide Competition Protocol (BPCP)
Blocking Peptide Competition Protocol (BPCP)
Immunoprecipitation (IP) Protocol
Immunoprecipitation (IP) Protocol
Antibody Array (AA) Protocol
Antibody Array (AA) Protocol
Format
Lyophilized powder
Reconstitution
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.
Molecular Weight
59kDa
Protein Length
501
Gene Name URL
SF3A3
Nucleotide Accession Number
NM_006802
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
